PUBLISHER: The Business Research Company | PRODUCT CODE: 1653382
PUBLISHER: The Business Research Company | PRODUCT CODE: 1653382
Single-chamber prefilled syringes are syringes that are pre-filled with a specific dose of medication in a single compartment. They are designed to facilitate easy and precise administration, minimizing the risk of dosing errors while enhancing convenience for both healthcare providers and patients.
The primary types of products in the category of single-chamber prefilled syringes include those made of glass and plastic. Glass-based single-chamber prefilled syringes are manufactured using glass, which is a commonly preferred material for such syringes. Plastic-based single-chamber prefilled syringes, on the other hand, utilize plastic as the preferred material. These syringes are designed for the injection of pre-filled vaccine products, biological substances, or pharmaceutical products.
The single-chamber prefilled syringes market research report is one of a series of new reports from The Business Research Company that provides single-chamber prefilled syringes market statistics, including single-chamber prefilled syringes industry global market size, regional shares, competitors with a single-chamber prefilled syringes market share, detailed single-chamber prefilled syringes market segments, market trends and opportunities, and any further data you may need to thrive in the single-chamber prefilled syringes industry. This single-chamber prefilled syringes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The single-chamber prefilled syringes market size has grown rapidly in recent years. It will grow from $10.72 billion in 2024 to $12.03 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to growth in pharmaceutical and biotechnology sectors, patient-friendly drug administration, safety and ease of use, demand for precise drug dosing, regulatory approvals and guidelines.
The single-chamber prefilled syringes market size is expected to see rapid growth in the next few years. It will grow to $22.44 billion in 2029 at a compound annual growth rate (CAGR) of 16.9%. The growth in the forecast period can be attributed to biologics and biosimilars in prefilled syringes, self-administration and home healthcare, pediatric and geriatric drug delivery, combination products with auto-injectors, regulatory emphasis on drug safety, telemedicine and remote monitoring. Major trends in the forecast period include prefilled syringes with connected devices, sustainable and biodegradable materials, customized and patient-specific syringe options, needlestick prevention and safety features, prefilled syringes for cell and gene therapies, prefilled syringes with anti-counterfeiting measures.
The increasing prevalence of chronic diseases, including diabetes and cancer, is driving the growth of the single-chamber prefilled syringe market. Patients with diabetes who require insulin therapy often utilize single-chamber prefilled syringes when medications are insufficient to manage their blood glucose levels. For example, in February 2024, the World Health Organization, a Switzerland-based agency dedicated to international public health, projected that by 2050, there will be over 35 million new cancer cases, representing a 77% increase from the estimated 20 million cases in 2022. Consequently, the rising prevalence of chronic diseases such as diabetes and cancer is fueling demand for single-chamber prefilled syringes.
The growing number of clinical trials is anticipated to drive the future growth of the single-chamber prefilled syringe market. Clinical trials, essential for evaluating the safety and effectiveness of new medical treatments, interventions, or drugs, require standardized and secure drug administration methods. Single-chamber prefilled syringes play a vital role in clinical trials by offering a safe and efficient means of drug delivery to research participants. Notably, the number of registered studies increased to 464,218 in August 2023 compared to 399,496 in 2021, according to ClinicalTrials.gov, covering all 50 states in the United States and 221 countries worldwide. The rising participation in clinical trials, with 31% in the U.S. and 53% in non-U.S. locations, is poised to be a significant factor propelling the single-chamber prefilled syringes market.
Technological advancements are shaping the landscape of the single-chamber prefilled syringe market. Leading companies in this sector are actively engaged in developing technological solutions to strengthen their market presence. For example, in September 2022, Otsuka America Pharmaceutical, Inc., and H. Lundbeck A/S introduced Aripiprazole 2-month, a ready-to-use, long-acting injectable form of aripiprazole delivered through a single-chamber prefilled syringe. The injection, designed for intramuscular administration every two months, offers a technologically advanced solution in the market.
Major industry players are strategically focusing on the development of generic injectable medicines like succinylcholine chloride injections to expand their product offerings. Succinylcholine Chloride Injection, available in prefilled syringe format, is prepared for direct intravenous or intramuscular dosing during surgery and ventilation without requiring dilution. Hikma Pharmaceuticals PLC, a multinational pharmaceutical company, introduced the first FDA-approved prefilled syringe for Succinylcholine Chloride Injection in the US market in October 2022.
In January 2022, Nordic Pharma Group acquired the ALTIM (cortivazol) prefilled syringe from Sanofi S.A. This strategic move aligns with Nordic Pharma's objectives of portfolio expansion and establishing a prominent position in rheumatology, with ALTIM being a prefilled syringe containing a 3.75 mg/1.5 ml cortivazol suspension for injection.
Major companies operating in the single-chamber prefilled syringes market include Becton, Dickinson and Company, Gerresheimer Glass Inc., Schott AG, Catalent Inc., Nipro Medical Corporation, Weigao Group Medical Polymer Company Limited, Stevanato Group S.p.A., Baxter International Inc., Vetter Pharma International GmbH, Terumo Corporation, Ypsomed Holding AG, SHL Medical AG, Ompi, Elcam Medical A.C.S. Ltd., Oval Medical Technologies Ltd., West Pharmaceutical Services Inc., Gerresheimer Regensburg GmbH, SCHOTT North America Inc., Vetter Pharma-Fertigung GmbH & Co. KG, Aptar Pharma Services Inc., Bespak Europe Ltd., Credence MedSystems Inc., Datwyler Pharma Packaging International Holding AG, Datwyler Sealing Solutions AG, Fresenius Kabi AG, Haselmeier GmbH, Hikma Pharmaceuticals PLC, HTL-STREFA S.A., Intas Pharmaceuticals Ltd.
North America was the largest region in the single-chamber prefilled syringes market in 2024. Asia-Pacific was the second largest region in the single-chamber prefilled syringes market share. The regions covered in the single-chamber prefilled syringes market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The countries covered in the single-chamber prefilled syringes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The single-chamber prefilled syringes market consists of sales of glass and plastic single-chamber prefilled syringes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Single-Chamber Prefilled Syringes Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on single-chamber prefilled syringes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for single-chamber prefilled syringes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The single-chamber prefilled syringes market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.